Knowledge attitude and practice of haemovigilance among doctors in tertiary care hospital in Nagpur, Maharashtra, India

Amit P. Date, Anjali A. Date, Amruta V. Dashputra, Archana S. Borkar


Background: Haemovigilance program of India was launched on December 2012 and is a comprehensive, and a well-structured approach to collect, collate, and analyse data to address the issues of adverse reactions associated with blood transfusion. The information thus collected would facilitate corrective and preventive actions to be taken to minimize the potential risk associated blood collection processing and transfusion to patients. Considering the deep concern over the under-reporting of transfusion reactions prevailing among the doctors, the present study was done to know the knowledge attitude and practice (KAP) of haemovigilance among doctors.

Methods: The present study was a cross sectional questionnaire based study, which included doctors of a tertiary care hospital. The purpose of the questionnaire was to know awareness of doctors regarding haemovigilance programme of India. With this study we also tried to   identify the factors responsible for underreporting of transfusion reactions and to find out the possible ways to improve reporting of transfusion reactions.

Results: (38.88%) and (30%) of the responders were aware of the haemovigilance programme and transfusion reaction reporting centre respectively. Reporting of transfusion reaction was poor 22.22% among the respondents. According to respondents creating awareness about haemovigilance by conducting continuing medical education (CMEs), and   training to healthcare professionals would lead to improvement in reporting of transfusion reactions. Complacency and ignorance were the main factors which discouraged transfusion reaction reporting by doctors.

Conclusions: Increasing awareness of haemovigilance among doctors and training on reporting transfusion reactions would likely improve spontaneous reporting and help to strengthen the blood transfusion system.


Haemovigilance, Transfusion reaction reporting, Underreporting

Full Text:



De Vries RRP, Faber JC, Strengers PFW. Haemovigilance: an effective tool for improving transfusion practice .The Int J of trans. Medicine. 2011:100;60-7.

Public health service (PHS). Biovigilance working group. Department of health and human services Washington, DC20201. Biovigilance in the United States: Efforts to bridge a critical gap in patient safety and donor health; 2009:16.

Commission directive 2005/61/EC of 30 September 2005 implementing Directive 2002/98/EC of the European parliament and of the council as regards traceability requirements and notification of serious adverse reactions and events. Official Journal of the European Union; 2005.

Faber JC. Haemovigilance procedure in transfusion medicine. Haematol J. 2004;5:74-82.

Faber JC. The European blood directive: a new era of blood regulation has begun. Transfus Med. 2004;14:257-73.

Jain A, Kaur R. Haemovigilance and blood safety. Asian J Transfus Sci. 2012;6:137-8.

Bisht A. Haemovigilance programme of India. Available at Accessed 11 February 2016.

Dheengra N. Haemovigilance in developing countries. Available at http// Accessed 5 February 2016.

World health organization .Who draft guidelines for adverse event reporting and learning system. 2005;1-80.

Paula HB, Maggs B, Hannah C. Serious hazards of transfusion (SHOT) haemovigilance and progress is improving transfusion safety. British Journal of Haematology. 2013;163:303-14.

Kaur G, Kaur P, Hospital transfusion committee: role and responsibilities. Ind J of patho and Microbiology. 2014:57(2);352-3.

Haynes SL, Torella F. The role of hospital transfusion committees in blood product conservation. Transfus Med Rev. 2004:18;93-104.

Napier JAF, Boultan FE, Guidelines for implementation of a maximum surgical blood order schedule. Clin lab Haemat. 1990:12;321-7.

Imam WH, Attitudes to adverse drug reaction reporting. Br J Clin Pharmacol. 1996;41:433-5.

Desai CK, Iyer G. An evaluation of KAP of ADR reporting among prescribers at a tertiary care hospital. Perspect clin Res. 2011;2(4):129-36.

Rehan HS, Vasudev K, Tripathi CD. Adverse drug reactions monitoring: knowledge, attitude and practices of medical students and prescribers. The National Medical Journal of India. 2002;15(1):24-6.

Radhakrishnan R, Vidyasagar S. An educational intervention to asses’ knowledge attitude practice of pharmacovigilance among healthcare professionals in an Indian tertiary care teaching hospital. International journal of pharma Tech research. 2011;3(2):678-92.

Thomas TM, Udaykumar P, Scandashree K. Knowledge attitude and practice of adverse drug reaction reporting among doctors in a tertiary centre in south India. Int J Pharmacol and Clin Sci. 2013;2:82-8.

Kharkar M, Bowalekar S. Knowledge attitude and practice (KAP) of medical practitioners in India towards adverse drug reaction (ADR) reporting. Perspect Clin Res. 2012;3:90-4.

Mishra H, Kumar V. Pharmacovigilance: current scenario in a tertiary care teaching medical college in North India. J pharmacovigilance. 2013;1(2):2-4.

World health organization. Blood transfusion safety 2006. Available at Accessed 2 February 2016.